UNSPSC 51281507: Ethionamide

This classification denotes an antitubercular agent with the molecular formula C8H10N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OAY8ORS3CQ, chemically known as cyclohexanol, 1-ethynyl-, carbamate but generally known as ethionamide, which bears US NIH Compound Identifier 3284. European Medicines Agency schedules Ethionamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07278MIG.

UNSPSC 51281507 Ethionamide is a Commodity code that in recent state and local procurement activity covers the purchase of prescription pharmaceuticals, over-the-counter medical products, and emergency medical supplies rather than ethionamide specifically. State and local governments soliciting under this code are acquiring naloxone and drug deactivation systems, generic multi-source pharmaceuticals distributed through authorized wholesalers, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription fulfillment capabilities. The issuing bodies include county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing alliances serving multiple state and local members. Seminole County, Florida; the Texas Health and Human Services Commission; the City of Tampa; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) have all posted opportunities under or aligned with this code in the past six months.

Recent opportunities show activity concentrated in Florida, Texas, and Minnesota, with MMCAP's multi-state reach extending to Oregon and other participating jurisdictions. Seminole County posted an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a July 26, 2026 response deadline; the contract is potentially FEMA-funded. The City of Tampa issued an ITB (Bid 26-P-00145) on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a March 13, 2026 due date, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. Minnesota's MMCAP issued an RFP on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with proposals due March 26, 2026. The Texas HHS Commission posted an RFI on April 3, 2026, to gather vendor capability information on direct-to-manufacturer prescription programs before issuing a formal RFP.